AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05920811 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional obturator
Description: restoration of midline maxillary defect with obturator made of cast metal , heat cure acrylic resin
Study NCT05920811 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3 d printed obturator
Description: restoration of midline maxillary defect with obturator made of SLM metal , 3 d printed resin
Study NCT04362800 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: MRI
Description: MRI at baseline and J90
Study NCT04362800 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MRI
Description: MRI at baseline and J90
Study NCT04362800 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Electro-Encephalography-High Density
Description: Electro-Encephalography-High Density (children with unilateral PC only) at baseline and J90
Study NCT04362800 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electro-Encephalography-High Density
Description: Electro-Encephalography-High Density (children with unilateral PC only) at baseline and J90
Study NCT04362800 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 3D and EMG analysis
Description: 3D and EMG analysis at baseline and J90
Study NCT04362800 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D and EMG analysis
Description: 3D and EMG analysis at baseline and J90
Study NCT04362800 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: care and classic activities
Description: physiotherapy and psychomotility. As needed weekly sessions of speech therapist or orthoptist and daily activities of the child.
Study NCT04362800 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: care and classic activities
Description: physiotherapy and psychomotility. As needed weekly sessions of speech therapist or orthoptist and daily activities of the child.
Study NCT06149221 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NTAP
Description: Cold plasma is generated and applied to the scalp area, which was previously soaked with normal saline
Study NCT04826991 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active UV Device
Description: Active water treatment system
Study NCT04826991 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Inactive UV Device
Description: Inactive water treatment system
Study NCT06268483 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: HA 100 mg, CS 400 mg, N-Acetylglucosamine 200 mg and vitamin C 80 mg + cranberry, D-mannose, propolis extract, tumeric and Boswellia
Description: Group I: an oral preparation (capsule) of HA 100 mg, CS 400 mg, N-Acetylglucosamine 200 mg and vitamin C 80 mg once a day in the morning plus an oral preparation of cranberry, D-mannose, propolis extract, tumeric and Boswellia twice a day for three months.
Study NCT06268483 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: cranberry, D-mannose, propolis extract, tumeric and Boswellia
Description: Group C: an oral preparation of cranberry, D-mannose, propolis extract, tumeric and Boswellia twice a day for three months.
Study NCT04436783 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Epley Maneuver System (VREMS)
Description: The VREMS system includes a smartphone placed inside virtual reality goggles worn by the participant. On the smartphone there is a virtual reality application. When viewed through the VR goggles the participants see a three-dimensional environment. Audio and text cues are presented in a 3D environment to help guide the patient through the Epley maneuver.
Study NCT04436783 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Instructional Handout (IH)
Description: Patients randomized to the IH group will be given an instructional handout with image and text-based instructions on the steps involved in performing the Epley maneuver. They will then be given the chance to perform the Epley maneuver.
Study NCT06370949 — intervention group
Intervention type: DRUG
Intervention: Bupivacain
Description: Ultrasonography (USG) guided bilateralTAP block:20 ml %0,25 concentration bupivacain
Study NCT06370949 — intervention group
Intervention type: DRUG
Intervention: bupivacain+dexmedetomidine
Description: Ultrasonography (USG) guided bilateral TAP block: 20 ml %0,25 concentration bupivacain+ 0.5 mcg/kg dexmedetomidine
Study NCT05300646 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prenatal mindfulness-based stress reduction
Description: An adapted mindfulness-based stress reduction (MBSR) program with a particular focus on pregnancy and early motherhood.
Study NCT04945473 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic placement of additional sutures
Description: A new endoscopic suture will be performed in case of a BMI≥30 or total weight loss (TBWL) less than 10%, and relaxation of gastric tubulization during the regular endoscopic follow-up after 6 months from the ESG. The same endoscopic suture technique of the primary ESG will be applied.
Study NCT06293534 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: TSH,T3,T4
Description: Diagnosis of the psychiatric disorders among study group will be assessed and recorded and history of Electroconvulsive therapy (ECT) also will be recorded , physical examination for signs that suggests actual thyroid disease such as unexplained bradycardia or tachycardia, hypothermia , goiter or non palpable thyroid among study group will be assessed
Study NCT05007197 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Effect of Diabetes Education Based on Learning Modality
Description: After controlling the metabolic values of the individuals in the intervention group, the education were carried out according to the learning modality of the people; Visual learners; education booklet, brochure, slides (enriched with pictures and videos), lecture, insulin injector-pen, glucose meters, introduction and demonstration of blood glucose tracking book Auditory learners; education booklet, slides, videos, lecture, question-answer, group work, peer group discussion, experience sharing Tactile learners; education booklet, slides, demonstration, insulin injector-pen, glucose meter doing the application of tools and equipment such as on the model, on himself, on his friend, filling in the blood glucose tracking book.~Group-specific diabetes trainings were completed in 2 training sessions. Each training session lasted an average of 1.5 hours The learning modality of the control group were determined and standard group training was provided with the education booklet.
Study NCT05580770 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirdametinib
Description: Mirdametinib administered orally
Study NCT05580770 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BGB-3245
Description: BGB-3245 administered orally
Study NCT05497739 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy
Description: 5-Fu 1 g/m\^2 on Days 1, 8, 15, and 22; Albumin-paclitaxel 80-100 mg/time on Days 1, 8, 15, and 22; Cisplatin 25 mg/m\^2 on Days 4, 11, 18, and 25; Interleukin-2 2 million units/time on Days 4, 11, 18, and 25.
Study NCT05497739 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adjuvant systemic chemotherapy
Description: Oxaliplatin 85 mg/m\^2 on Day 1; S-1 depends on Body Surface Area (BSA), 40 mg Bid, Days 1-10 (BSA \< 1.25 m\^2), 50 mg Bid, Days 1-10 (BSA 1.25-1.50 m\^2), 60 mg Bid, Days 1-10 (BSA > 1.50 m\^2).
Study NCT05679661 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: immunonutrition
Description: Patients in the intervention group will receive additional immunonutrition supplementation, which is oral intake of ORAL IMPACT™ 2 servings per day from the day of allocation at the preoperative anesthesia clinic until the day before surgery.
Study NCT05679661 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: oral chlorhexidine decontamination
Description: Patients in the intervention group will receive oral chlorhexidine decontamination using 0.12% chlorhexidine oral rinse twice daily from the day before surgery until postoperative day 3.
Study NCT04716686 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niraparib
Description: Patients received oral niraparib 200/300 mg QD and every cycle (28 days) thereafter until disease progression.
Study NCT06513741 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mentoring Workshop
Description: Faculty mentoring workshop with the title Faculty Mentoring; building stronger by digging deeper was designed as a two-day workshop of three hours each for the faculty members of the two institutions at separate times
Study NCT05382884 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Postpartumcare.ca (Web-Enabled Intervention)
Description: Postpartumcare.ca is a web-enabled intervention accessible via computer, tablet or smartphone devices. The content and design of postpartumcare.ca were created based on the needs, opinions, and desires of birthing parents in British Columbia affected by postpartum depression and/or anxiety, which were solicited previously in phases 1 \& 2 of the SUPPORT study.
Study NCT05545787 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cold snare endoscopic mucosal resection
Description: During CS-EMR, methylene blue-tinted epinephrine saline will be injected into the submucosal space around the lesion to lift the lesion. The polyp and 1-2mm of surrounding mucosa will then be closely snared and transected mechanically.
Study NCT05545787 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hot snare endoscopic mucosal resection
Description: During HS-EMR, methylene blue-tinted epinephrine saline will be injected into the submucosal space around the lesion to lift the lesion. The snare will be placed around the lesion, and then cautery will be applied using the electrosurgical generator.
Study NCT04830306 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Completion of exercise in accordance with assigned protocol
Study NCT04107636 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vacuum assisted biopsy
Description: First, the tumor will be removed under local anesthesia using the VAB system with US guidance, through a small skin incision (\<0.5 cm). A localization marker will be placed in the biopsy cavity, to help determine the cavity location.
Study NCT04107636 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional lumpectomy
Description: After 3 weeks, the breast conserving surgery is performed, excising the VAB excision cavity and a ≥1 cm of surrounding tissue, as deemed appropriate by the attending breast surgeon. A sentinel node biopsy will be performed in the same procedure.
Study NCT03481842 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Linifanib
Description: in a minimally sufficient therapeutic dose
Study NCT03481842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBW2992
Description: in a minimally sufficient therapeutic dose
Study NCT03481842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Axitinib
Description: in a minimally sufficient therapeutic dose
Study NCT05944159 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study Group
Description: Study Group (n= 20) was recieved Temporomandibular joint ve soft tissue techniques. The techniques were applied 30 minutes once a week for 4 weeks by physiotherapist to the study group.
Study NCT05944159 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: Routin medication therapy was applied to the control group. Both groups were asked to do the home exercise program twice a day consisting of vestibular exercise videos sent over whatss app. It was questioned with a phone call once a week whether the exercises were done or not.
Study NCT05464238 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise rehabilitation
Description: The initial phase of exercise training will be closely monitored and will be based on a three-weeks in-hospital stay to adjust and teach the exercise training which will be continued at home for 12 more weeks. In-hospital stays will be arranged country specific and hospitalization time may range. The rehabilitation program comprises of interval ergometer training (20 minutes 5 days per week), dumbbell training (30 minutes 5 days per week), respiratory therapy (30 minutes 5 days per week), mental training and guided walks for 2-5 times/week.
Study NCT05464238 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard treatment
Description: Standard treatment during study duration
Study NCT05132387 — intervention group
Intervention type: OTHER
Intervention: ECMO assisted CPR in out-of-hospital cardiac arrest
Description: Patients included in the registry will be transferred during LUCAS assisted CPR by the Wroclaw Emergency Medical Services to the Emergency Department of the Wroclaw University Hospital where blood gasses will be assessed. If two or more of the following: end-tidal carbon dioxide (CO2) > 10 mm Hg, arterial partial pressure of oxygen (PaO2) >50 mm Hg or oxygen saturation >85%, and lactic acid \<18 mmol/L will be fulfilled patient will be further transferred to the Cardiac Catheterization Laboratory for V-A ECMO implantation followed by coronary/pulmonary artery angiography and intervention.
Study NCT05018195 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Excise adipose tissue
Description: Perform partial omentectomy to obtain one 5\*5 cm omental fat and excise one 3\*3 cm subcutaneous adipose tissue( 2 finger width above the pubic symphysis) during surgery
Study NCT05018195 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Excise adipose tissue
Description: Perform partial omentectomy to obtain one 5\*5 cm omental fat and excise one 3\*3 cm subcutaneous adipose tissue( 2 finger width above the pubic symphysis) during surgery
Study NCT06206382 — intervention group
Intervention type: PROCEDURE
Intervention: Whipple operation
Description: Whipple operation is the surgery used for pancreatic head cancer in the form of pancreaticoduodenectomy then reconstruction
Study NCT05296356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OSU6162
Description: OSU6162
Study NCT05097313 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Yeast β-glucan fiber
Description: The study is designed to determine if β-glucan is safe and if it presents an antioxidant and immunomodulatory response in healthy adults in Colombia.
Study NCT05097313 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral consumption of 200 mg (one capsule) or 400 mg (two capsules) of soy protein powder for 84 days.
Study NCT06223243 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stingless bee honey mouthrinse
Description: Three bottles of 90ml of stingless bee honey of 20% concentration was given to each subject. This mouthrinse preparation was instructed for subjects to be taken 30ml each, thrice daily for three days.
Study NCT06223243 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: normal saline mouthrinse
Description: Subjects were instructed to rinse with 30ml of normal saline (0.9% concentration) thrice daily for three days.
Study NCT06223243 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: chlorhexidine mouthrinse
Description: Subjects were instructed to rinse with 30ml of chlorhexidine mouthrinse thrice daily for three days.
Study NCT05840237 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Anhydrous Enol-Oxaloacetate, a Medical Food
Description: Treatment with the medical food Oxaloacetate CFS, 2 - 500 mg capsules BID with food
Study NCT05840237 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: White Rice Flour
Description: Treatment with the food White Rice Flour, 2- 500 mg capsules BID with food
Study NCT05310162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Food, fun and family
Description: The intervention consists of a series of change of habits in the way children eat, the reduction of the recreational time of screens and healthy habits of physical activity. This intervention, which is called Food, Fun \& Family (FFF), is aimed at parents and has been shown to be effective in reducing the consumption of empty calories by children. It teaches parents skills to reduce their daily energy intake of added sugars and saturated fats, it also seeks to reduce screen time.~The intervention contains information and recommendations, through guides, in which precise instructions are given about how to maintain a healthy environment at home.
Study NCT06413095 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Intratumoral microdose injection by the CIVO device.
Study NCT06413095 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: MK-0482 + Pembrolizumab
Description: Intratumoral microdose injection by the CIVO device.
Study NCT06413095 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: MK-4830 + Pembrolizumab
Description: Intratumoral microdose injection by the CIVO device.
Study NCT05398055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin + Doxycycline
Description: azithromycin 500 mg orally every 24 hours for three dose plus doxycycline 100 mg orally every 12 hours for 7 days
Study NCT05398055 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo + Doxycycline
Description: doxycycline 100 mg orally every 12 hours for 7 days plus placebo 1 capsule every 24 hours, 3 doses
Study NCT05607823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core Stabilization Training
Description: Core Stabilization training will be based on dynamic neuromuscular stabilization and consists of three stages. In the first session, it is to teach the simultaneous activation of the transversus abdominis, pelvic floor, multifidus and diaphragm muscles and to improve muscle coordination and proprioception in the entire spinal region. In the second and third phases, exercises will be made more intense to improve muscular endurance and stability. The difficulty of the exercises will be increased by working in different positions, using resistance bands, exercise balls and body weight, and adding movements to the extremities. A total of 10 sessions of treatment program will be applied to the patients for ten weeks, once a week.
Study NCT05607823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Orofacial Manual Therapy
Description: As orofacial manual therapy, soft tissue (intraoral and extraoral trigger point therapy and myofascial release of painful muscles) and joint mobilization (caudal and ventro-caudal traction, ventral and mediolateral translation), muscle energy technique, fascia mandibularis release, occipital release and ligamentous treatment was planned.
Study NCT05607823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physiotherapy
Description: Conventional physiotherapy consists of home exercise and patient education. Patient education consists of parafunctional behaviors, habits, a diet with soft food, and posture education. The exercises consist of exercises for the mandible, cervical and thoracic region and breathing. All movements are planned to be done at home 3 times a day, every day of the week.
Study NCT05310162 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Counseling
Description: Simple verbal instructions will be given in the consultation to reduce the time of use of screens and refined sugar.~For refined sugar reduction, parents will be told to avoid sugary drinks, add sugar to drinks (juices, milk, etc.), and avoid snacks and sweets. It will also be indicated that the screen time should be less than two hours a day and in no case use them two hours before sleeping.
Study NCT05375526 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magtrace
Description: In the proper ovarian ligament (or its remnants), close to the ovary and just below the peritoneum Magtrace® will be injected via a 12 Gauge (2mm) needle. This injection will be followed by an injection of 20 MBq 99mTc via the same 12 Gauge (2mm) needle.~If a hysterectomy has been conducted, this step can be omitted. In the infundibulopelvic ligament (suspensory ligament of the ovary), close to the ovary and just below the peritoneum Magtrace® will be injected via a 12 Gauge (2mm) needle. This injection will be followed by an injection of 20 MBq 99mTc via the same 12 Gauge (2mm) needle.
Study NCT05004558 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote-based Resistance Exercise Training
Description: All participants enrolled in the trial will receive supervised remote-based resistance exercise training. The exercises will be performed with the use of Therabands and will include 8-10 exercises performed for 1 set of 15 repetitions, performed 3 days per week for 24 weeks.
Study NCT05673434 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TM4SF1-positive chimeric antigen receptor T-cell therapy
Description: Specification: 50mL/bag. Storage: The prepared CAR T-cells are cryopreserved in a preserving medium . This product is manufactured under the current good manufacture practices (cGMP) conditions, with restrictions on chemical components, free from animal- or human-derived components and confirming to the United States Pharmacopeia (USP)\<71> and \<85> regulations.~Preservation: The frozen CAR T-cells are preserved in the liquid nitrogen transfer tank.~Usage: The frozen CAR T-cells are preserved at low temperature and transferred to the bedside. The cells are thawed by 36 degrees centigrade to 38 degrees centigrade. water bath. The frozen cells are gently massaged until complete thawing. Then they are transfused back to the patients intravenously. The transfusion will be finished within 10-20 min.
Study NCT04403789 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Time
Description: Employees will be provided with exercise time of 2 hours per week. The 2 hours should be used in two days. The intervention duration is 12 weeks.